Anaphore Raises $25 Million
Anaphore Inc., a developer of protein therapeutics to address cancer and immune-mediated diseases, has raised $25 million in Series A funding. The round includes an $8 million seed funding that closed last March, while the remainder closed in December. Apposite Capital was joined on the second tranche by seed backers 5am Ventures and Versant Ventures.
7 January 2009•4 mins read
